Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 May 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1297.70 [ -0.60% ]TCS 2559.15 [ +1.49% ]

Sensex30301.64
-63.61 -0.21%

Nifty9360.55
-25.60 -0.27%

Midcap14037.70
-203.18 -1.43%

Smallcap14556.57
-213.29 -1.44%



Alembic Pharmaceuticals Ltd :

 580.20  -12.80 [-2.16%]

ISIN: INE901L01018  | NSE: APLLTD |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 533573  |  Add To Watchlist

Price Information
• Open 590.00
• High 590.00
• Low 557.30
• Previous Close 593.00
• Shares Traded 727900
• 52 Wk High Price 709.30
• 52 Wk High Date 23-03-2017
• 52 Wk Low Price 517.90
• 52 Wk Low Date 24-06-2016
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 11313.80
• EPS (Rs.)(TTM) 22.80
• P/E Ratio(TTM) 26.30
• Book Value (Rs.) 99.10
• Price to Book Value 6.05
• Equity (Rs.cr.) 37.70
• Traded Value (Rs.lac) 28.49


Corporate Actions
Ex-Date Purpose (Rs.)
2012-07-31 70% Dividend (1.4)
2013-07-29 125% Dividend (2.5)
2014-07-17 150% Dividend (3)
2015-07-22 175% Dividend (3.5)
2016-07-20 200% Dividend (4)


Index Names
BSE HC
BSE Small Cap
BSE-200
BSE-500


Related Companies
Stock Name Price
BAJAJTEMPO 4140.60




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Mar, 2017 Mar, 2017 Mar, 2017
• Sales (Rs.cr) 647.03 2985.90 2985.90
• Net Profit (Rs.cr) 59.24 430.63 430.63
• Net Profit Var (%) -33.00 -38.00 -38.00
• EPS (Rs) - 22.80 22.80
• P/E Ratio - 26.30 26.30
• Operating Profit Margin - 21.20 -
• CPS (Rs.) - - 27.20
• P/C Ratio - - 22.00
• Div% - - 200.00

Announcements
28-04-2016 Board of Alembic Pharmaceuticals recommends final dividend
29-06-2012 Alembic and Breckenridge announce paragraph IV ANDA litigation with Pfizer on desvenlafaxine (Prist
15-06-2012 Alembic Pharma settles patent litigation with Novartis for generic version of Exelon
03-03-2017 Alembic Pharmaceuticals announces launch of desvenlafaxine succinate ER tablets
18-11-2016 Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets
05-12-2016 Alembic Pharmaceuticals gets ANDA approval for Zolmitriptan Orally Disintegrating Tablets
22-10-2012 Alembic Pharmaceuticals received final approval for Modfinil tablets
15-05-2017 Alembic Pharmaceuticals receives ANDA approval for Fenofibric Acid Delayed-Release Capsules
07-04-2017 Alembic Pharmaceuticals receives ANDA approval for Fluoxetine Hydrochloride Tablets
16-12-2016 Alembic Pharmaceuticals receives ANDA approval for Itraconazole Capsules
02-05-2016 Alembic Pharmaceuticals receives final approval for Lacosamide Tablets
25-04-2017 Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hy
05-07-2016 Alembic Pharmaceuticals receives tentative approval for Febuxostat Tablets
03-05-2013 Alembic Pharmaceuticals Recommends Dividend
12-04-2012 Alembic Pharmaceuticals to consider dividend
05-06-2014 Alembic Pharmaceuticals to hold AGM
26-09-2014 Alembic Pharmaceuticals to hold board meeting
21-04-2016 Alembic Pharmaceuticals to set up JV with Orbicular
27-04-2015 Board of Alembic Pharmaceuticals appoints directors
10-01-2017 Board of Alembic Pharmaceuticals to consider Q3 results
28-07-2014 Outcome of board meeting of Alembic Pharmaceuticals

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
23-05-2017 1143 1759 64.98 677799 1044.18
22-05-2017 2676 4751 56.32 1606136 2848.66
19-05-2017 2004 3357 59.70 1203102 2015.53
18-05-2017 601 1989 30.22 362524 1204.22
17-05-2017 1746 3675 47.51 1062529 2229.68


Bulk Deals
Deal Date Client Name Type Qty Price
23-03-2017 SHRENO LI B 1000000 595.00
23-03-2017 VIRAMYA P S 1000000 595.00


Block Deals
Deal Date Client Name Type Qty Price
24-03-2017 SIERRA INVESTMENTS LIMITED B 170000 602.00
24-03-2017 SHRENO LIMITED B 530000 602.00
24-03-2017 VIRAMYA PACKLIGHT LLP S 170000 602.00
24-03-2017 VIRAMYA PACKLIGHT LLP S 530000 602.00
23-03-2017 SHRENO LI B 1000000 595.00


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  malanpur steel ltd  •  tata che  •  aurobindo pharma  •  exide industries  •  holding
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech